Cormorant Asset Management, LP
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1583977
BOSTON, MA
Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,592,000
-$1,273,000 QoQ
Shares Held
200,000
-42.9% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#60
of 207 holders
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $62,185,728 across 2 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIOA |
BioAge Labs, Inc.
|
2,390,605 | $58,593,728 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
200,000 | $3,592,000 |
All Filings in AMLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,592,000 | 200,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,865,000 | 350,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,832,000 | 400,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,795,000 | 500,000 | Shares | Defined | 2025-11-14 | |
| 2022-12-31 | $20,322,500 | 550,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,171,500 | 610,000 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||